{"id":5425,"date":"2018-12-14T18:50:27","date_gmt":"2018-12-14T17:50:27","guid":{"rendered":"http:\/\/agora.xtec.cat\/institutcanplanas\/?p=5425"},"modified":"2019-11-15T18:18:17","modified_gmt":"2019-11-15T17:18:17","slug":"xerrades-de-la-marato-2","status":"publish","type":"post","link":"https:\/\/agora.xtec.cat\/institutcanplanas\/general\/xerrades-de-la-marato-2\/","title":{"rendered":"Xerrades de \u201cLa Marat\u00f3\u201d"},"content":{"rendered":"<p>Avui divendres els alumnes d&#8217;ESO han pogut anar a la xerrada de \u201c<a href=\"https:\/\/www.ccma.cat\/tv3\/marato\/2018\/210\/\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>La Marat\u00f3<\/strong><\/a>\u201c.<\/p>\n<p><img decoding=\"async\" src=\"https:\/\/1.bp.blogspot.com\/-DutbJ1Wae4c\/Xc2YxSWf7cI\/AAAAAAAAUxc\/ahRrTnopHXcBYhVOfZjnJozgdub3wKD4wCLcBGAsYHQ\/s1600\/IMG_20181213_113749.jpg\" \/><!--more--><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/1.bp.blogspot.com\/-_hY7WxqUVEI\/Xc2YwjaXSkI\/AAAAAAAAUxU\/CPwcPr0f-k4N3Ggd-XmJoFlxEvnpjRHvACLcBGAsYHQ\/s1600\/IMG_20181213_113731.jpg\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/1.bp.blogspot.com\/-R_lc6spNKoY\/Xc2Ywz5R58I\/AAAAAAAAUxY\/Z6OnhKRTBGQxnkZ9ikQ_snryMOU-oWxEwCLcBGAsYHQ\/s1600\/IMG_20181213_113739.jpg\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/1.bp.blogspot.com\/-WvCBJzG-WMY\/Xc2YyS8_-kI\/AAAAAAAAUxg\/UEit1oTOecsRIMsibOx9qJz0Fh4xF2h4gCLcBGAsYHQ\/s1600\/IMG_20181213_113802.jpg\" \/><\/p>\n<p>El c\u00e0ncer \u00e9s la\u00a0<strong>primera causa de mort a Catalunya<\/strong>\u00a0entre els homes i, la segona, entre les dones. Cada dia moren 28 persones de c\u00e0ncer, \u00e9s a dir, m\u00e9s de 10.000 a l&#8217;any.<\/p>\n<p>Gr\u00e0cies a la investigaci\u00f3 biom\u00e8dica, a Catalunya,\u00a0<strong>la superviv\u00e8ncia al c\u00e0ncer ha crescut un 7% en els \u00faltims 10 anys<\/strong>\u00a0i la mitjana se situa, actualment, en el 55%. Per\u00f2 malgrat els aven\u00e7os que s&#8217;han fet en tractaments, m\u00e8todes de diagn\u00f2stic i prevenci\u00f3,\u00a0<strong>la incid\u00e8ncia del c\u00e0ncer segueix sent molt alta:<\/strong><\/p>\n<p><strong>1 de cada 2 homes i 1 de cada 3 dones tindran c\u00e0ncer al llarg de la seva vida.<\/strong><\/p>\n<p>Cal seguir investigant per millorar la superviv\u00e8ncia de les persones que tindran aquesta malaltia.<\/p>\n<h2 class=\"titol-gran\">Qu\u00e8 \u00e9s el c\u00e0ncer<\/h2>\n<p>Les c\u00e8l\u00b7lules del nostre cos creixen i es divideixen per formar c\u00e8l\u00b7lules noves, que reemplacen les que es van morint. Per\u00f2, de vegades, aquest cicle s&#8217;altera i\u00a0<strong>les c\u00e8l\u00b7lules no moren quan ho haurien de fer i creixen de forma\u00a0<\/strong>invasiva sense els controls biol\u00f2gics normals del cos hum\u00e0. Aquest proc\u00e9s s&#8217;anomena c\u00e0ncer. Aquestes c\u00e8l\u00b7lules poden generar tumors, envair teixits propers i escampar-se per altres parts del cos i formar una met\u00e0stasi.<\/p>\n<p>En realitat, una mateixa paraula ens serveix per referir-nos a m\u00e9s de\u00a0<strong>200 tipus diferents de malalties<\/strong>: mama, c\u00f2lon, pulm\u00f3, cervell, leuc\u00e8mia, limfoma, p\u00e0ncrees&#8230;<\/p>\n<p>Generalment, el c\u00e0ncer rep el nom del lloc del cos on comen\u00e7a. Si s&#8217;est\u00e9n a altres \u00f2rgans o teixits es produeix el que en diem\u00a0<strong>met\u00e0stasi<\/strong>.<\/p>\n<h2 class=\"titol-gran\">Quins tumors s\u00f3n els m\u00e9s freq\u00fcents<\/h2>\n<p>En els\u00a0<strong>homes<\/strong>, els c\u00e0ncers m\u00e9s habituals s\u00f3n els de\u00a0<strong>pr\u00f2stata<\/strong>\u00a0(amb un superviv\u00e8ncia del 90%), el\u00a0<strong>colorectal\u00a0<\/strong>(amb una superviv\u00e8ncia del 55%) i el de\u00a0<strong>pulm\u00f3<\/strong>\u00a0(amb un percentatge de superviv\u00e8ncia baix, del 15%, despr\u00e9s de 5 anys des del moment del diagn\u00f2stic).<\/p>\n<p>En les\u00a0<strong>dones<\/strong>, el tumor m\u00e9s freq\u00fcent \u00e9s el de\u00a0<strong>mama<\/strong>\u00a0(amb una superviv\u00e8ncia del 90%), el\u00a0<strong>colorectal<\/strong>\u00a0(amb un 55% de superviv\u00e8ncia) i el d&#8217;<strong>endometri<\/strong>\u00a0(que amb una superviv\u00e8ncia del 76% aviat quedar\u00e0 desbancat pel de pulm\u00f3).<\/p>\n<h2 class=\"titol-gran\">Podem prevenir el c\u00e0ncer?<\/h2>\n<p>Els experts calculen que\u00a0<strong>m\u00e9s del 40% dels c\u00e0ncers es poden prevenir<\/strong>\u00a0si se segueixen unes pautes de vida saludable:<\/p>\n<p><strong>No fumar<\/strong><br \/>\nEl consum de\u00a0tabac\u00a0\u00e9s un dels factors de risc m\u00e9s importants en un gran nombre de c\u00e0ncers i en la majoria de malalties cardiovasculars i respirat\u00f2ries.<\/p>\n<p><strong>Activitat f\u00edsica moderada<\/strong><br \/>\nLa pr\u00e0ctica regular d&#8217;exercici redueix la possibilitat de desenvolupar alguns c\u00e0ncers, com, per exemple, el de c\u00f2lon. Tots podem fer coses tan senzilles com caminar mitja hora a pas r\u00e0pid cada dia o pujar escales.<\/p>\n<p><strong>Seguir una dieta saludable i controlar el pes\u00a0<\/strong><br \/>\nHi ha una\u00a0forta evid\u00e8ncia\u00a0que es pot reduir el risc de c\u00e0ncer amb h\u00e0bits alimentaris saludables.\u00a0\u00c9s recomanable seguir una \u00a0dieta variada com la mediterr\u00e0nia i menjar m\u00e9s peix, fruita i verdura.<\/p>\n<p><strong>Limitar el consum d&#8217;alcohol\u00a0<\/strong><br \/>\nLes begudes alcoh\u00f2liques augmenten el risc de molts tipus de c\u00e0ncer (coll, es\u00f2fag, laringe, c\u00f2lon, fetge o p\u00e0ncrees). Cal limitar-ne el consum.<\/p>\n<p><strong>Evitar l&#8217;exposici\u00f3 excessiva al sol\u00a0<\/strong><br \/>\nCal prendre el sol amb molta moderaci\u00f3 i evitar les hores de m\u00e9s sol, especialment els nens. Les cremades a la pell s\u00f3n la causa del melanoma, un c\u00e0ncer, en principi, poc freq\u00fcent, per\u00f2 que cada any augmenta.<\/p>\n<p><strong>Vacunar-se<\/strong><br \/>\nLes vacunes ens poden protegir d&#8217;alguns virus associats a certs c\u00e0ncers, com el virus del papil\u00b7loma hum\u00e0, que causa c\u00e0ncer de c\u00e8rvix, i l&#8217;hepatitis,<strong>\u00a0<\/strong>que pot desencadenar c\u00e0ncer de fetge.<\/p>\n<p><strong>Fer les proves de detecci\u00f3 preco\u00e7\u00a0<\/strong><br \/>\nAlguns c\u00e0ncers, si es detecten aviat, poden tenir molt bon pron\u00f2stic, com el de mama, el de coll d&#8217;\u00fater i el de c\u00f2lon i recte. Les proves indicades de cribratge s\u00f3n: una mamografia cada dos anys (dels 50 als 69 anys), una citologia ginecol\u00f2gica cada tres anys i una prova de sang oculta en femta cada dos anys (a partir dels 50).<\/p>\n<h2 class=\"titol-gran\">La recerca<\/h2>\n<p>Hi ha un 60% dels c\u00e0ncers que no sabem com es poden prevenir. Ens aquests casos, l&#8217;objectiu de la investigaci\u00f3 \u00e9s trobar m\u00e8todes per diagnosticar-los el m\u00e9s aviat possible i, aix\u00ed, poder aplicar tractaments m\u00e9s efica\u00e7os i augmentar-ne la superviv\u00e8ncia. Una gran oportunitat en aquest camp rau en el diagn\u00f2stic molecular del c\u00e0ncer que ens permet personalitzar els tractaments. En els propers anys tamb\u00e9 podrem veure el desenvolupament de la\u00a0<strong>bi\u00f2psia l\u00edquida<\/strong>\u00a0que, gr\u00e0cies a una an\u00e0lisi de sang, ser\u00e0 capa\u00e7 de detectar productes de les c\u00e8l\u00b7lules cancer\u00edgenes abans, fins i tot, de tenir cap s\u00edmptoma i sense haver d&#8217;intervenir el pacient per obtenir mostres del seu tumor.<\/p>\n<p>Pel que fa als tractaments, cal seguir fent recerca en la\u00a0<strong>immunoter\u00e0pia<\/strong>, que estimula el sistema immunitari propi de l&#8217;organisme per fer-lo lluitar contra el c\u00e0ncer. Tamb\u00e9 cal avan\u00e7ar en els procediments multidisciplinaris actuals que combinen\u00a0<strong>tractaments biol\u00f2gics\u00a0<\/strong>dirigits a propietats de les c\u00e8l\u00b7lules malignes,\u00a0<strong>quimioter\u00e0pia, radioter\u00e0pia i cirurgia,<\/strong>\u00a0perqu\u00e8 cada cop siguin m\u00e9s personalitzats i, per tant, m\u00e9s efectius.<\/p>\n<p>Un dels camps que genera una gran expectativa \u00e9s el de la bioinform\u00e0tica i el tractament del\u00a0<em>bigdata<\/em>\u00a0relacionat amb el c\u00e0ncer. Fa falta programari i eines capaces d&#8217;analitzar tones de dades gen\u00e8tiques de pacients de c\u00e0ncer de tot el m\u00f3n per treure&#8217;n conclusions i ajustar cada cop m\u00e9s les ter\u00e0pies.<\/p>\n<p>El tractament del c\u00e0ncer en les persones de m\u00e9s de 75 anys i la millora de la qualitat de vida dels llargs supervivents de c\u00e0ncer s\u00f3n, tamb\u00e9, dos dels reptes de la investigaci\u00f3.<\/p>\n<p><iframe loading=\"lazy\" src=\"https:\/\/www.youtube.com\/embed\/FkcWyrPkLAQ\" width=\"640\" height=\"360\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Avui divendres els alumnes d&#8217;ESO han pogut anar a la xerrada de \u201cLa Marat\u00f3\u201c.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1,29],"tags":[115,45,129,44],"class_list":["post-5425","post","type-post","status-publish","format-standard","hentry","category-general","category-portada","tag-c-experimentals","tag-salut","tag-tutoria","tag-xerrades"],"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/agora.xtec.cat\/institutcanplanas\/wp-json\/wp\/v2\/posts\/5425","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/agora.xtec.cat\/institutcanplanas\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/agora.xtec.cat\/institutcanplanas\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/agora.xtec.cat\/institutcanplanas\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/agora.xtec.cat\/institutcanplanas\/wp-json\/wp\/v2\/comments?post=5425"}],"version-history":[{"count":3,"href":"https:\/\/agora.xtec.cat\/institutcanplanas\/wp-json\/wp\/v2\/posts\/5425\/revisions"}],"predecessor-version":[{"id":5958,"href":"https:\/\/agora.xtec.cat\/institutcanplanas\/wp-json\/wp\/v2\/posts\/5425\/revisions\/5958"}],"wp:attachment":[{"href":"https:\/\/agora.xtec.cat\/institutcanplanas\/wp-json\/wp\/v2\/media?parent=5425"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/agora.xtec.cat\/institutcanplanas\/wp-json\/wp\/v2\/categories?post=5425"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/agora.xtec.cat\/institutcanplanas\/wp-json\/wp\/v2\/tags?post=5425"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}